GPATCH4 Inhibitors
GPATCH4 inhibitors pertain to a class of chemical compounds designed to interact with the GPATCH4 (G-patch domain-containing protein 4) protein. This protein is characterized by the presence of a G-patch domain, which is a specialized sequence of amino acids known to be involved in RNA processing. GPATCH4 plays a notable role in the splicing of pre-mRNA, which is a critical step in the maturation of messenger RNA (mRNA) before it is translated into proteins. The splicing process ensures that non-coding sequences, or introns, are removed and the coding sequences, or exons, are joined together. Inhibitors targeting GPATCH4 are thus involved in modulating the function of this protein, affecting the RNA splicing mechanism. The design of these molecules is informed by the structural biology of the G-patch domain, taking advantage of the unique folding and binding characteristics that can be manipulated to influence GPATCH4 activity.
Chemically, GPATCH4 inhibitors are diverse, but they share the common goal of interacting with the GPATCH4 protein to modulate its function. These molecules can vary greatly in size, shape, and composition, reflecting the different strategies employed to achieve high-affinity binding to the target protein. To design an effective GPATCH4 inhibitor, scientists often utilize a combination of computer-aided drug design and empirical structure-activity relationships to identify key functional groups or scaffolds that interact with the G-patch domain. This process involves screening a variety of compounds for their ability to bind to and alter the function of GPATCH4, with subsequent optimization to improve the specificity and potency of the interactions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor. Given that mTOR plays a role in protein synthesis and other cellular processes, influencing this pathway can have an indirect effect on GPATCH4 if it's involved in such processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor. PI3K is involved in many signaling pathways related to cell growth and survival. If GPATCH4 plays a part in these pathways, Wortmannin can potentially modulate its function or expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor. By inhibiting PI3K, it can affect downstream processes or pathways that GPATCH4 may be involved in. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor. JNK plays roles in cellular stress responses. If GPATCH4 is involved in stress-related processes, then SP600125 can indirectly modulate its functionality. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, a kinase involved in stress and inflammation. If GPATCH4 has roles within these cellular responses, its function can be influenced by SB203580. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that impacts the MAPK/ERK pathway. Given that the MAPK/ERK pathway regulates a wide range of cellular functions, it's possible that GPATCH4, if involved, can be indirectly modulated by PD98059. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glucose analog and glycolysis inhibitor. If GPATCH4 is involved in energy metabolism or pathways related to glycolysis, its function or expression might be influenced by 2-DG. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
AMPK activator and an inhibitor of mitochondrial respiratory chain complex 1. Given that AMPK regulates various cellular processes, GPATCH4, if involved in such pathways, might be indirectly modulated by Metformin. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
A pan-caspase inhibitor. If GPATCH4 plays roles in apoptosis or related pathways, its functionality might be influenced by Z-VAD-FMK. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
An inhibitor of vacuolar-type H+-ATPase, affecting endocytic and autophagic pathways. If GPATCH4 is linked to vesicular transport or autophagy, its function or expression can be indirectly modulated by Bafilomycin A1. | ||||||